Albert James Chang

Title(s)Department Vice Chair, Radiation Oncology
SchoolMedicine
vCardDownload vCard
    Other Positions
    Title(s)Professor Of Clinical, Radiation Oncology

    Title(s)Professor Of Clinical, Urology


    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Salvage percutaneous high-dose-rate brachyablation after stereotactic body radiation therapy for early-stage non-small cell lung cancer. J Contemp Brachytherapy. 2024 Apr; 16(2):150-155. Wu TC, Lee A, Suh R, Oughourlian TC, Abtin F, Hagio MA, Park SJ, Chang AJ, Moghanaki D. PMID: 38808204; PMCID: PMC11129647.
      View in: PubMed   Mentions:
    2. Selecting the optimal radiation modality in prostate cancer. Clin Adv Hematol Oncol. 2023 Sep; 21(9):494-501. Valle LF, Kishan AU, Franco A, Ma TM, Nikitas J, Farrell M, Chang AJ, Nickols NG, Steinberg ML. PMID: 37647496.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Analytical HDR prostate brachytherapy planning with automatic catheter and isotope selection. Med Phys. 2023 Oct; 50(10):6525-6534. Frank CH, Ramesh P, Lyu Q, Ruan D, Park SJ, Chang AJ, Venkat PS, Kishan AU, Sheng K. PMID: 37650773; PMCID: PMC10635680.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study. Radiother Oncol. 2023 07; 184:109672. Corkum MT, Buyyounouski MK, Chang AJ, Chung HT, Chung P, Cox BW, Crook JM, Davis BJ, Frank SJ, Henriquez I, Horwitz EM, Hoskin P, Hsu IC, Keyes M, King MT, Kollmeier MA, Krauss DJ, Kukielka AM, Morton G, Orio PF, Pieters BR, Potters L, Rossi PJ, Showalter TN, Solanki AA, Song D, Vanneste B, Vigneault E, Wojcieszek PA, Zelefsky MJ, Kamrava M. PMID: 37059334.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    5. Multimodality Therapies for Localized Prostate Cancer. Curr Oncol Rep. 2023 03; 25(3):221-229. Valle LF, Jiang T, Weiner AB, Reiter RE, Rettig MB, Shen J, Chang AJ, Nickols NG, Steinberg ML, Kishan AU. PMID: 36723856; PMCID: PMC11288626.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Bladder only versus bladder plus pelvic lymph node chemoradiation for muscle-invasive bladder cancer. Urol Oncol. 2023 07; 41(7):325.e15-325.e23. Patel SA, Liu Y, Solanki AA, Baumann BC, Efstathiou JA, Jani AB, Chang AJ, Fischer-Valuck B, Royce TJ. PMID: 36725382.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Association of Brachytherapy Boost with Overall Survival for Gleason 9-10 Prostate Cancer: The Impact of Primary versus Secondary Pattern 5. Brachytherapy. 2023 May-Jun; 22(3):310-316. Patel SA, Baumann B, Michalski J, Brenneman R, Zheng B, Gay H, Ferraro D, Brown SA, Chang AJ, Rossi PJ, Fischer-Valuck BW. PMID: 36635202.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 Trial. Adv Radiat Oncol. 2022 Sep-Oct; 7(5):100941. Shee K, de la Calle CM, Chang AJ, Wong AC, Feng FY, Gottschalk AR, Carroll PR, Nguyen HG. PMID: 35847550; PMCID: PMC9280039.
      View in: PubMed   Mentions: 3  
    9. Rectal Radiation Dose and Clinical Outcomes in Prostate Cancer Patients Treated With Stereotactic Body Radiation Therapy With and Without Hydrogel. Front Oncol. 2022; 12:853246. Kundu P, Lin EY, Yoon SM, Parikh NR, Ruan D, Kishan AU, Lee A, Steinberg ML, Chang AJ. PMID: 35350564; PMCID: PMC8957858.
      View in: PubMed   Mentions: 2  
    10. Safety of accelerated hypofractionated whole pelvis radiation therapy prior to high dose rate brachytherapy or stereotactic body radiation therapy prostate boost. Radiat Oncol. 2022 Jan 20; 17(1):12. Phuong C, Chan JW, Ni L, Wall P, Mohamad O, Wong AC, Hsu IC, Chang AJ. PMID: 35057827; PMCID: PMC8772149.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. High-Dose Rate Interstitial Spine Brachytherapy Using an Intraoperative Mobile Computed Tomography-Guided Surgical Navigation System. Oper Neurosurg (Hagerstown). 2021 11 15; 21(6):507-515. Medina R, Macyszyn L, Lim AS, Attiah M, Kafka-Peterson K, Kaprelian T, Hegde JV, Venkat P, Lee A, Park SJ, Chang AJ. PMID: 34670276.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Trends and Predictors of Hypofractionated and Intensity-Modulated Radiotherapy for Organ Preservation in Bladder Cancer. Clin Genitourin Cancer. 2022 04; 20(2):e94-e103. Xiang M, Chang AJ, Chamie K, Drakaki A, Pollom EL, Steinberg ML, Kishan AU. PMID: 34866018.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. American Brachytherapy Society radiation oncology alternative payment model task force: Quality measures and metrics for brachytherapy. Brachytherapy. 2022 Jan-Feb; 21(1):63-74. Shah C, Vicini F, Beriwal S, Thaker N, Frank SJ, Rossi P, Orio P, Chang AJ, Joshi N, Campbell SR, Naghavi A, Chao S, Kamrava M, Deufel CL, Mourtada F, Suh JH. PMID: 34732290.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Socioeconomic and Racial Determinants of Brachytherapy Utilization for Cervical Cancer: Concerns for Widening Disparities. JCO Oncol Pract. 2021 12; 17(12):e1958-e1967. Boyce-Fappiano D, Nguyen KA, Gjyshi O, Manzar G, Abana CO, Klopp AH, Kamrava M, Orio PF, Thaker NG, Mourtada F, Venkat P, Chang AJ. PMID: 34550749; PMCID: PMC8678033.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    15. Society of Interventional Radiology Multidisciplinary Position Statement on Percutaneous Ablation of Non-small Cell Lung Cancer and Metastatic Disease to the Lungs: Endorsed by the Canadian Association for Interventional Radiology, the Cardiovascular and Interventional Radiological Society of Europe, and the Society of Interventional Oncology. J Vasc Interv Radiol. 2021 Aug; 32(8):1241.e1-1241.e12. Genshaft SJ, Suh RD, Abtin F, Baerlocher MO, Chang AJ, Dariushnia SR, Devane AM, Faintuch S, Himes EA, Lisberg A, Padia S, Patel S, Tam AL, Yanagawa J. PMID: 34332724.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    16. Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features. JAMA Netw Open. 2021 07 01; 4(7):e2115312. Kishan AU, Karnes RJ, Romero T, Wong JK, Motterle G, Tosoian JJ, Trock BJ, Klein EA, Stish BJ, Dess RT, Spratt DE, Pilar A, Reddy C, Levin-Epstein R, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Braccioforte M, Huland H, Tran PT, Martin S, Martínez-Monge R, Krauss DJ, Abu-Isa EI, Alam R, Schwen Z, Chang AJ, Pisansky TM, Choo R, Song DY, Greco S, Deville C, McNutt T, DeWeese TL, Ross AE, Ciezki JP, Boutros PC, Nickols NG, Bhat P, Shabsovich D, Juarez JE, Chong N, Kupelian PA, D'Amico AV, Rettig MB, Berlin A, Tward JD, Davis BJ, Reiter RE, Steinberg ML, Elashoff D, Horwitz EM, Tendulkar RD, Tilki D. PMID: 34196715; PMCID: PMC8251338.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    17. Payment Methodology for the Radiation Oncology Alternative Payment Model: Implications for Practices and Suggestions for Improvement. JCO Oncol Pract. 2021 12; 17(12):761-764. Boyce-Fappiano D, Ning MS, Gjyshi O, Mesko S, Pasalic D, Chang AJ, Orio PF, Thaker NG. PMID: 34097458.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Outcomes with multi-disciplinary management of central lung tumors with CT-guided percutaneous high dose rate brachyablation. Radiat Oncol. 2021 Jun 07; 16(1):99. Yoon SM, Suh R, Abtin F, Moghanaki D, Genshaft S, Kamrava M, Drakaki A, Liu S, Venkat P, Lee A, Chang AJ. PMID: 34098977; PMCID: PMC8186067.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    19. Use of stereotactic body radiotherapy in gynecologic cancers: Local control with systemic treatment implications. Gynecol Oncol. 2020 12; 159(3):599-600. Cohen JG, Chang AJ. PMID: 33279016.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. Trends in Use and Comparison of Stereotactic Body Radiation Therapy, Brachytherapy, and Dose-Escalated External Beam Radiation Therapy for the Management of Localized, Intermediate-Risk Prostate Cancer. JAMA Netw Open. 2020 09 01; 3(9):e2017144. Nguyen KA, Lee A, Patel SA, Chakravorty A, Yu JB, Kishan AU, Chang AJ. PMID: 32970153; PMCID: PMC7516602.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    21. Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients. Radiother Oncol. 2020 10; 151:26-32. Levin-Epstein R, Cook RR, Wong JK, Stock RG, Jeffrey Demanes D, Collins SP, Aghdam N, Suy S, Mantz C, Katz AJ, Nickols NG, Miszczyk L, Napieralska A, Namysl-Kaletka A, Prionas ND, Bagshaw H, Buyyounouski MK, Cao M, Mahal BA, Shabsovich D, Dang A, Yuan Y, Rettig MB, Chang AJ, Jackson WC, Spratt DE, Lehrer EJ, Zaorsky NG, Kupelian PA, Steinberg ML, Horwitz EM, Jiang NY, Kishan AU. PMID: 32663537.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    22. Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials. Eur Urol. 2020 02; 77(2):201-208. Kishan AU, Chu FI, King CR, Seiferheld W, Spratt DE, Tran P, Wang X, Pugh SE, Sandler KA, Bolla M, Maingon P, De Reijke T, Nickols NG, Rettig M, Drakaki A, Liu ST, Reiter RE, Chang AJ, Feng FY, Sajed D, Nguyen PL, Kupelian PA, Steinberg ML, Boutros PC, Elashoff D, Collette L, Sandler HM. PMID: 31718822; PMCID: PMC7008470.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    23. The American Brachytherapy Society consensus statement on intraoperative radiation therapy. Brachytherapy. 2019 May - Jun; 18(3):242-257. Tom MC, Joshi N, Vicini F, Chang AJ, Hong TS, Showalter TN, Chao ST, Wolden S, Wu AJ, Martin D, Husain Z, Badiyan SN, Kolar M, Sherertz T, Mourtada F, Cohen GN, Shah C. PMID: 31084904.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    24. Single-fraction brachytherapy as monotherapy for early-stage prostate cancer: The UCSF experience. Brachytherapy. 2019 Jul - Aug; 18(4):470-476. Xu MJ, Chen KS, Chang AJ, Lazar A, Shinohara K, Cunha JAM, Hsu IC. PMID: 30954399.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    25. Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate Cancer. Eur Urol Oncol. 2021 04; 4(2):327-330. Wang C, Raldow AC, Nickols NG, Nguyen PL, Spratt DE, Dess RT, Yu JB, King CR, Chu FI, Chamie K, Litwin MS, Saigal CS, Reiter RE, Liu ST, Rettig MB, Chang AJ, Steinberg ML, Kupelian PA, Kishan AU. PMID: 31411981.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. Impact of Staging 68Ga-PSMA-11 PET Scans on Radiation Treatment Plansin Patients With Prostate Cancer. Urology. 2019 03; 125:154-162. Wu SY, Boreta L, Shinohara K, Nguyen H, Gottschalk AR, Hsu IC, Roach M, Westphalen AC, Feng FY, Carroll PR, Chang AJ, Hope TA. PMID: 30580002.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    27. In Reply to Gensheimer and Trister. Int J Radiat Oncol Biol Phys. 2018 12 01; 102(5):1594-1596. Valdes G, Chang AJ, Cunnan A, Solberg TD, Hsu IC, Interian Y, Owen K, Jensen ST, Ungar LH. PMID: 31014789.
      View in: PubMed   Mentions:    Fields:    
    28. The American Brachytherapy Society and the American Radium Society Appropriate Use Criteria Genitourinary Committee Endorse the American Society of Clinical Oncology/Cancer Care Ontario Guidelines. J Clin Oncol. 2018 Sep 13; JCO1800626. Chang AJ, McBride S, Keyes M, Chung HT, Davis BJ, Cox BW, Crook J, Demanes DJ, Hsu IC, Kamrava M, Krauss DJ, Morton G, Orio Iii PF, Roach Iii M, Venkat PS, Vigneault E, Zelefsky MJ. PMID: 30212298.
      View in: PubMed   Mentions:    Fields:    
    29. Salvage HDR Brachytherapy: Multiple Hypothesis Testing Versus Machine Learning Analysis. Int J Radiat Oncol Biol Phys. 2018 07 01; 101(3):694-703. Valdes G, Chang AJ, Interian Y, Owen K, Jensen ST, Ungar LH, Cunha A, Solberg TD, Hsu IC. PMID: 29709315.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    30. Improved rectal dosimetry with the use of SpaceOAR during high-dose-rate brachytherapy. Brachytherapy. 2018 Mar - Apr; 17(2):259-264. Wu SY, Boreta L, Wu A, Cheung JP, Cunha JAM, Shinohara K, Chang AJ. PMID: 29203149.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    31. Imaging PD-L1 Expression with ImmunoPET. Bioconjug Chem. 2018 01 17; 29(1):96-103. Truillet C, Oh HLJ, Yeo SP, Lee CY, Huynh LT, Wei J, Parker MFL, Blakely C, Sevillano N, Wang YH, Shen YS, Olivas V, Jami KM, Moroz A, Jego B, Jaumain E, Fong L, Craik CS, Chang AJ, Bivona TG, Wang CI, Evans MJ. PMID: 29125731; PMCID: PMC5773933.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansAnimalsCells
    32. A novel urethral sparing technique for high-dose-rate prostate brachytherapy after transurethral resection of the prostate. Brachytherapy. 2017 Nov - Dec; 16(6):1113-1118. Kunogi H, Cunha JAM, Chang AJ, Gadzinski AJ, Shinohara K, Hsu IC. PMID: 28869143.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    33. Respiration-Induced Intraorgan Deformation of the Liver: Implications for Treatment Planning in Patients Treated With Fiducial Tracking. Technol Cancer Res Treat. 2017 Dec; 16(6):776-782. Paulsson AK, Yom SS, Anwar M, Pinnaduwage D, Sudhyadhom A, Gottschalk AR, Chang AJ, Descovich M. PMID: 28071340; PMCID: PMC5762032.
      View in: PubMed   Mentions: 4     Fields:    
    34. 18F Fluorocholine Dynamic Time-of-Flight PET/MR Imaging in Patients with Newly Diagnosed Intermediate- to High-Risk Prostate Cancer: Initial Clinical-Pathologic Comparisons. Radiology. 2017 Feb; 282(2):429-436. Choi JY, Yang J, Noworolski SM, Behr S, Chang AJ, Simko JP, Nguyen HG, Carroll PR, Kurhanewicz J, Seo Y. PMID: 27513849; PMCID: PMC5283870.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    35. Receiver operating curves and dose-volume analysis of late toxicity with stereotactic body radiation therapy for prostate cancer. Pract Radiat Oncol. 2017 Mar - Apr; 7(2):e109-e116. Zhang L, Johnson J, Gottschalk AR, Chang AJ, Hsu IC, Roach M, Seymour ZA. PMID: 28274401.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    36. Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical Cystectomy. Int J Radiat Oncol Biol Phys. 2016 09 01; 96(1):78-86. Baumann BC, Bosch WR, Bahl A, Birtle AJ, Breau RH, Challapalli A, Chang AJ, Choudhury A, Daneshmand S, El-Gayed A, Feldman A, Finkelstein SE, Guzzo TJ, Hilman S, Jani A, Malkowicz SB, Mantz CA, Master V, Mitra AV, Murthy V, Porten SP, Richaud PM, Sargos P, Efstathiou JA, Eapen LJ, Christodouleas JP. PMID: 27511849; PMCID: PMC5207044.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    37. Patient- and treatment-specific predictors of genitourinary function after high-dose-rate monotherapy for favorable prostate cancer. Brachytherapy. 2015 Nov-Dec; 14(6):795-800. Raleigh DR, Chang AJ, Tomlin B, Cunha JA, Braunstein SE, Shinohara K, Gottschalk AR, Roach M, Hsu IC. PMID: 26198421.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    38. Patterns of Local Failure following Radiation Therapy for Prostate Cancer. J Urol. 2015 Oct; 194(4):977-82. Jalloh M, Leapman MS, Cowan JE, Shinohara K, Greene KL, Roach M, Chang AJ, Chan JM, Simko JP, Carroll PR. PMID: 25983194.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    39. Dose-volume analysis and the temporal nature of toxicity with stereotactic body radiation therapy for prostate cancer. Pract Radiat Oncol. 2015 Sep-Oct; 5(5):e465-e472. Seymour ZA, Chang AJ, Zhang L, Kirby N, Descovich M, Roach M, Hsu IC, Gottschalk AR. PMID: 25795252.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    40. Bladder wall recurrence of prostate cancer after high-dose-rate brachytherapy. Brachytherapy. 2015 Mar-Apr; 14(2):185-8. Raleigh DR, Hsu IC, Braunstein S, Chang AJ, Simko JP, Roach M. PMID: 25533416.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    41. Editorial comment. Urology. 2014 Dec; 84(6):1387-8. Chang AJ. PMID: 25475226.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    42. High-risk prostate cancer-classification and therapy. Nat Rev Clin Oncol. 2014 Jun; 11(6):308-23. Chang AJ, Autio KA, Roach M, Scher HI. PMID: 24840073; PMCID: PMC4508854.
      View in: PubMed   Mentions: 205     Fields:    Translation:Humans
    43. Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: comparison of PSA slope and nadir. Radiat Oncol. 2014 Feb 02; 9:42. Anwar M, Weinberg V, Chang AJ, Hsu IC, Roach M, Gottschalk A. PMID: 24484652; PMCID: PMC3923240.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    44. Roles of Atox1 and p53 in the trafficking of copper-64 to tumor cell nuclei: implications for cancer therapy. J Biol Inorg Chem. 2014 Mar; 19(3):427-38. Beaino W, Guo Y, Chang AJ, Anderson CJ. PMID: 24445997; PMCID: PMC3951176.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    45. Positron emission tomographic imaging of copper 64- and gallium 68-labeled chelator conjugates of the somatostatin agonist tyr3-octreotate. Mol Imaging. 2014; 13. Nedrow JR, White AG, Modi J, Nguyen K, Chang AJ, Anderson CJ. PMID: 25060207; PMCID: PMC4265553.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    46. Detection of rapalog-mediated therapeutic response in renal cancer xenografts using ⁶⁴Cu-bevacizumab immunoPET. PLoS One. 2013; 8(3):e58949. Chang AJ, Sohn R, Lu ZH, Arbeit JM, Lapi SE. PMID: 23516584; PMCID: PMC3597567.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    47. Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes. Int J Radiat Oncol Biol Phys. 2013 Jun 01; 86(2):324-9. Chen CP, Weinberg V, Shinohara K, Roach M, Nash M, Gottschalk A, Chang AJ, Hsu IC. PMID: 23474112.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansPHPublic Health
    48. Prognostic value of 18F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma. J Radiat Oncol. 2013 Mar; 2(1):27-34. Garsa AA, Chang AJ, Dewees T, Spencer CR, Adkins DR, Dehdashti F, Gay HA, Thorstad WL. PMID: 24563726; PMCID: PMC3929054.
      View in: PubMed   Mentions: 8  
    49. Cautious optimism for extreme dose escalation in prostate cancer. Eur Urol. 2013 Dec; 64(6):939-40. Chang AJ, Roach M. PMID: 23506832.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    50. Development and characterization of 89Zr-labeled panitumumab for immuno-positron emission tomographic imaging of the epidermal growth factor receptor. Mol Imaging. 2013 Jan-Feb; 12(1):17-27. Chang AJ, De Silva RA, Lapi SE. PMID: 23348788; PMCID: PMC4329987.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    51. Utility of normal tissue-to-tumor α/β ratio when evaluating isodoses of isoeffective radiation therapy treatment plans. Int J Radiat Oncol Biol Phys. 2013 Jan 01; 85(1):e81-7. Gay HA, Jin JY, Chang AJ, Ten Haken RK. PMID: 23141886.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    52. Radium-223: down to the bone, and less is more. Oncology (Williston Park). 2012 Apr; 26(4):342, 344. Chang AJ, Roach M. PMID: 22655526.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    53. 89Zr-Radiolabeled Trastuzumab Imaging in Orthotopic and Metastatic Breast Tumors. Pharmaceuticals (Basel). 2012 Jan 05; 5(1):79-93. Chang AJ, Desilva R, Jain S, Lears K, Rogers B, Lapi S. PMID: 24288044; PMCID: PMC3763623.
      View in: PubMed   Mentions: 31  
    54. Video surface image guidance for external beam partial breast irradiation. Pract Radiat Oncol. 2012 Apr-Jun; 2(2):97-105. Chang AJ, Zhao H, Wahab SH, Moore K, Taylor M, Zoberi I, Powell SN, Klein EE. PMID: 24674085.
      View in: PubMed   Mentions: 17     Fields:    
    55. The role of positron emission tomography for non-small cell lung cancer. Pract Radiat Oncol. 2011 Oct-Dec; 1(4):282-8. Chang AJ, Dehdashti F, Bradley JD. PMID: 24674007.
      View in: PubMed   Mentions: 3     Fields:    
    56. Split-field helical tomotherapy with or without chemotherapy for definitive treatment of cervical cancer. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):263-9. Chang AJ, Richardson S, Grigsby PW, Schwarz JK. PMID: 21167656.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    57. Clinical perspectives on dose escalation for non-small-cell lung cancer. Clin Lung Cancer. 2010 Sep 01; 11(5):299-302. Chang AJ, Bradley JD. PMID: 20837454.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    58. Attenuation of peroxisome proliferator-activated receptor gamma (PPARgamma) mediates gastrin-stimulated colorectal cancer cell proliferation. J Biol Chem. 2006 May 26; 281(21):14700-10. Chang AJ, Song DH, Wolfe MM. PMID: 16574647.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    59. Effects of nonselective cyclooxygenase inhibition with low-dose ibuprofen on tumor growth, angiogenesis, metastasis, and survival in a mouse model of colorectal cancer. Clin Cancer Res. 2005 Feb 15; 11(4):1618-28. Yao M, Zhou W, Sangha S, Albert A, Chang AJ, Liu TC, Wolfe MM. PMID: 15746067.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    60. Gastrin stimulates receptor-mediated proliferation of human esophageal adenocarcinoma cells. Regul Pept. 2004 Aug 15; 120(1-3):195-203. Moore TC, Jepeal LI, Boylan MO, Singh SK, Boyd N, Beer DG, Chang AJ, Wolfe MM. PMID: 15177938.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    61. Fulminant Hepatic Failure. Curr Treat Options Gastroenterol. 2003 Dec; 6(6):473-479. Chang AJ, Dixit V, Saab S. PMID: 14585236.
      View in: PubMed   Mentions:
    62. Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation. Liver Transpl. 2003 Oct; 9(10):1053-61. Saab S, Chang AJ, Comulada S, Geevarghese SK, Anselmo RD, Durazo F, Han S, Farmer DG, Yersiz H, Goldstein LI, Ghobrial RM, Busuttil RW. PMID: 14526400.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    Albert's Networks
    Concepts (241)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (70)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-5-g94c7c43e on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California